Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Croda counsel's associate invests almost £0.1m

(Sharecast News) - Croda International was at the top of the buyers' list on Tuesday, after it disclosed a purchase worth almost £0.1m linked to its general counsel. The FTSE 100 company said Sarah Brophy bought 1,401 of its shares at 7,099p each on 10 March, making the purchase worth £99,456.93.

Sarah Brophy was linked in the disclosure to Croda's company secretary and group general counsel, Tom Brophy.

On the selling side of the ledger, meanwhile, were some high-value transactions, with Hikma Pharmaceuticals reporting that its chief executive officer Sigurdur Olafsson had sold 16,299 shares.

The FTSE 100 firm said Olafsson sold the shares for 1,988p each, netting him £324,024.11 to cover his tax bill after vesting 26,377 incentive plan award shares.

PageGroup also disclosed share sales to cover HMRC liabilities, with chief executive officer Steve Ingham selling 92,047 shares and chief financial officer Kelvin Stagg selling 45,813 shares, both at a price of 493.4p each.

The FTSE 250 company said Ingham's £454,159.90 sale covered his tax and national insurance bill after he received 195,354 incentive shares, while Stagg had £226,041.34 to send to the revenue after receiving 97,228 shares.

Top Director Buys

Croda International (CRDA) Director name: Brophy ,Tom Amount purchased: 1,401 @ 7,099.00p Value: £99,456.93

Novacyt S.a. (cdi) (NCYT) Director name: McCarthy,James Amount purchased: 37,310 @ 201.00p Value: £74,993.10

Lancashire Holdings Limited (LRE) Director name: Kershaw,Natalie Amount purchased: 12,438 @ 401.87p Value: £49,984.59

Novacyt S.a. (cdi) (NCYT) Director name: McCarthy,James Amount purchased: 2,360 @ 212.00p Value: £5,003.20

British Land Company (BLND) Director name: Carter,Simon Amount purchased: 30 @ 508.12p Value: £152.44

British Land Company (BLND) Director name: Mistry,Bhavesh Amount purchased: 30 @ 508.12p Value: £152.44

Bae Systems (BA.) Director name: Woodburn,Charles Amount purchased: 20 @ 743.82p Value: £148.76

Bae Systems (BA.) Director name: Greve,Brad Amount purchased: 20 @ 743.82p Value: £148.76

Emis Group (EMIS) Director name: Southby,Peter Amount purchased: 12 @ 1,210.00p Value: £145.20

Top Director Sells

Hikma Pharmaceuticals (HIK) Director name: Olafsson,Sigurdur Amount sold: 27,498 @ 1,988.00p Value: £546,660.22

Pagegroup (PAGE) Director name: Ingham,Stephen Amount sold: 92,047 @ 493.40p Value: £454,159.90

Hikma Pharmaceuticals (HIK) Director name: Olafsson,Sigurdur Amount sold: 16,299 @ 1,988.00p Value: £324,024.11

Pagegroup (PAGE) Director name: Stagg ,Kelvin Amount sold: 45,813 @ 493.40p Value: £226,041.34

Derwent London (DLN) Director name: George,Nigel Q Amount sold: 2,474 @ 3,090.46p Value: £76,457.98

Derwent London (DLN) Director name: Williams,Paul M. Amount sold: 2,474 @ 3,090.46p Value: £76,457.98

Derwent London (DLN) Director name: Silverman,David Amount sold: 2,474 @ 3,090.46p Value: £76,457.98

Reach (RCH) Director name: Fuller,Simon Amount sold: 42,005 @ 178.42p Value: £74,945.74

Chemring Group (CHG) Director name: Lewis,Andrew Amount sold: 18,000 @ 333.94p Value: £60,109.20

Derwent London (DLN) Director name: Williams,Paul M. Amount sold: 1,881 @ 3,090.46p Value: £58,131.55

Derwent London (DLN) Director name: Silverman,David Amount sold: 1,601 @ 3,090.46p Value: £49,478.26

Derwent London (DLN) Director name: George,Nigel Q Amount sold: 1,601 @ 3,090.46p Value: £49,478.26

Derwent London (DLN) Director name: Wisniewski,Damian Amount sold: 1,601 @ 3,090.46p Value: £49,478.26

Derwent London (DLN) Director name: Prideaux,Emily Amount sold: 676 @ 3,090.46p Value: £20,891.51

Ilika (IKA) Director name: Boydell,Stephen John Amount sold: 2,000 @ 118.00p Value: £2,360.00

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.